USO PARA MANTENIMIENTO DE LINOMIDE(R)
LA PRESENTE INVENCION SE REFIERE AL USO DE LINOMIDO, POR EJEMPLO N-FENIL-N-METIL-1,2-DIHIDRO-4-HIUDROXI-1-METIL-2-OXO QUINOLINA-3-CARBOXAMIDA PARA EL TRATAMIENTO DE HUMANOS EXPUESTOS A BMT, IRRADIACIONES DE TRATAMIENTOS CITOSTATICOS Y TRATAMIENTOS DE LOS MISMOS. The present invention concerns the us...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | KALLAND, TERJE NILSSON, BO TERMANDER, BIRGITTA |
| description | LA PRESENTE INVENCION SE REFIERE AL USO DE LINOMIDO, POR EJEMPLO N-FENIL-N-METIL-1,2-DIHIDRO-4-HIUDROXI-1-METIL-2-OXO QUINOLINA-3-CARBOXAMIDA PARA EL TRATAMIENTO DE HUMANOS EXPUESTOS A BMT, IRRADIACIONES DE TRATAMIENTOS CITOSTATICOS Y TRATAMIENTOS DE LOS MISMOS.
The present invention concerns the use of Linomide, i.e. N-phenyl-N-methyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-quinoline-3-car boxamide for the treatment of humans subjected to BMT, cytostatic treatment irradiations or combinations thereof. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ES2089206TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ES2089206TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ES2089206TT33</originalsourceid><addsrcrecordid>eNrjZFANDfZXCHAMclTwdfQLcfXz9PV09QvxV3BxVfDx9PP39XRx1QjS5GFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8a7BRgYWlkYGZiEhxsbEqAEAkDgjdA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>USO PARA MANTENIMIENTO DE LINOMIDE(R)</title><source>esp@cenet</source><creator>KALLAND, TERJE ; NILSSON, BO ; TERMANDER, BIRGITTA</creator><creatorcontrib>KALLAND, TERJE ; NILSSON, BO ; TERMANDER, BIRGITTA</creatorcontrib><description>LA PRESENTE INVENCION SE REFIERE AL USO DE LINOMIDO, POR EJEMPLO N-FENIL-N-METIL-1,2-DIHIDRO-4-HIUDROXI-1-METIL-2-OXO QUINOLINA-3-CARBOXAMIDA PARA EL TRATAMIENTO DE HUMANOS EXPUESTOS A BMT, IRRADIACIONES DE TRATAMIENTOS CITOSTATICOS Y TRATAMIENTOS DE LOS MISMOS.
The present invention concerns the use of Linomide, i.e. N-phenyl-N-methyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-quinoline-3-car boxamide for the treatment of humans subjected to BMT, cytostatic treatment irradiations or combinations thereof.</description><edition>6</edition><language>spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1996</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19961001&DB=EPODOC&CC=ES&NR=2089206T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19961001&DB=EPODOC&CC=ES&NR=2089206T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KALLAND, TERJE</creatorcontrib><creatorcontrib>NILSSON, BO</creatorcontrib><creatorcontrib>TERMANDER, BIRGITTA</creatorcontrib><title>USO PARA MANTENIMIENTO DE LINOMIDE(R)</title><description>LA PRESENTE INVENCION SE REFIERE AL USO DE LINOMIDO, POR EJEMPLO N-FENIL-N-METIL-1,2-DIHIDRO-4-HIUDROXI-1-METIL-2-OXO QUINOLINA-3-CARBOXAMIDA PARA EL TRATAMIENTO DE HUMANOS EXPUESTOS A BMT, IRRADIACIONES DE TRATAMIENTOS CITOSTATICOS Y TRATAMIENTOS DE LOS MISMOS.
The present invention concerns the use of Linomide, i.e. N-phenyl-N-methyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-quinoline-3-car boxamide for the treatment of humans subjected to BMT, cytostatic treatment irradiations or combinations thereof.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1996</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFANDfZXCHAMclTwdfQLcfXz9PV09QvxV3BxVfDx9PP39XRx1QjS5GFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8a7BRgYWlkYGZiEhxsbEqAEAkDgjdA</recordid><startdate>19961001</startdate><enddate>19961001</enddate><creator>KALLAND, TERJE</creator><creator>NILSSON, BO</creator><creator>TERMANDER, BIRGITTA</creator><scope>EVB</scope></search><sort><creationdate>19961001</creationdate><title>USO PARA MANTENIMIENTO DE LINOMIDE(R)</title><author>KALLAND, TERJE ; NILSSON, BO ; TERMANDER, BIRGITTA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ES2089206TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>1996</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KALLAND, TERJE</creatorcontrib><creatorcontrib>NILSSON, BO</creatorcontrib><creatorcontrib>TERMANDER, BIRGITTA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KALLAND, TERJE</au><au>NILSSON, BO</au><au>TERMANDER, BIRGITTA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>USO PARA MANTENIMIENTO DE LINOMIDE(R)</title><date>1996-10-01</date><risdate>1996</risdate><abstract>LA PRESENTE INVENCION SE REFIERE AL USO DE LINOMIDO, POR EJEMPLO N-FENIL-N-METIL-1,2-DIHIDRO-4-HIUDROXI-1-METIL-2-OXO QUINOLINA-3-CARBOXAMIDA PARA EL TRATAMIENTO DE HUMANOS EXPUESTOS A BMT, IRRADIACIONES DE TRATAMIENTOS CITOSTATICOS Y TRATAMIENTOS DE LOS MISMOS.
The present invention concerns the use of Linomide, i.e. N-phenyl-N-methyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-quinoline-3-car boxamide for the treatment of humans subjected to BMT, cytostatic treatment irradiations or combinations thereof.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | spa |
| recordid | cdi_epo_espacenet_ES2089206TT3 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | USO PARA MANTENIMIENTO DE LINOMIDE(R) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T08%3A35%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KALLAND,%20TERJE&rft.date=1996-10-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EES2089206TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |